Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Clinical trial NCT01767155 · COMPLETED
Trial details
- NCT number
- NCT01767155
- Sponsor
- AEterna Zentaris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2017-01-30
- Enrollment
- 511
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.